LRMR — Larimar Therapeutics, Inc.

LRMRLarimar Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · larimartx.com

3.485USD+1.60%Mkt Cap: 363.07M USDP/E: —Last update: 2026-06-01

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601,…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap363.07M USD

Enterprise Value166.65M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-165.67M USD

Revenue/Share—

Last Price3.485 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees71

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-2.84

PEG—

EV/EBITDA-0.97

EV/Revenue—

P/S—

P/B2.30

EPS (TTM)-2.12

EPS (Forward)-1.23

52W Range

2.12032% of range6.420

52W High6.420 USD

52W Low2.120 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-212.17%

ROA-113.60%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-113.20M USD

CapEx (TTM)91.00K USD

FCF Margin—

FCF Yield-19.64%

Net Debt-196.61M USD

Net Debt/EBITDA1.14

Balance Sheet

Debt/Equity0.05

Current Ratio4.29

Quick Ratio4.21

Book Value/Sh1.514 USD

Cash/Share1.920 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateMay 29, 2020

Analyst Consensus

Rating1.2 (Strong Buy)

Target (Mean)15.11 USD

Target Range7.000 USD – 26.00 USD

# Analysts9

Ownership

Shares Out.103.88M

Float59.99M

Insiders1.10%

Institutions85.55%

Short Interest

Short Ratio5.4d

Short % Float13.00%

Short % Out.8.42%

Shares Short8.74M

Short (prev mo.)7.33M

Technical

SMA 504.321 (-19.3%)

SMA 2004.017 (-13.2%)

Beta0.91

S&P 52W Chg27.94%

Avg Vol (30d)1.58M

Avg Vol (10d)1.97M

Technical Indicators

RSI (14)35.4

MACD-0.2603

MACD Signal-0.2570

MACD Hist.-0.0033

BB Upper4.395 USD

BB Middle3.754 USD

BB Lower3.112 USD

BB Width34.17%

ATR (14)0.2466 USD

Vol Ratio (20d)0.37x